Carbohydrate Drink Before Cesarean Section for Newborn Blood Glucose
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a carbohydrate-rich drink before a planned cesarean section affects a newborn's blood sugar levels. Researchers aim to understand how this drink might aid mothers and their babies in recovering better after surgery. Participants will be divided into groups: some will receive the carbohydrate preoperative drink, while others will receive standard care. Pregnant women not in labor and planning a cesarean delivery may be suitable for this trial. As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could enhance recovery outcomes for mothers and babies.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that drinks containing carbohydrates are generally well-tolerated by patients undergoing cesarean sections. These drinks can reduce feelings of thirst, hunger, and anxiety before surgery. They may also aid recovery by easing post-surgery discomfort and improving the body's insulin response.
No major side effects have been reported with these drinks. They are available for purchase and have been used safely in other medical situations. However, discussing any concerns or specific health conditions, such as diabetes, with a doctor before using these drinks is important.12345Why are researchers excited about this trial?
Researchers are excited about using a carbohydrate drink before a cesarean section because it could help stabilize newborn blood glucose levels more effectively than standard fasting protocols. Typically, patients fast before surgery, but this drink, taken two hours prior, provides a safe energy source that might prevent low blood sugar in newborns. This approach is particularly innovative because it offers a simple, non-invasive method to potentially improve outcomes for both diabetic and non-diabetic mothers and their babies.
What evidence suggests that this trial's treatments could be effective for neonatal glucose levels?
Research has shown that drinking a carbohydrate-rich beverage before a cesarean section can be beneficial. In this trial, some participants will receive a commercially available preoperative carbohydrate drink, while others will not receive any intervention. Studies have found that the drink reduces feelings of thirst and hunger in mothers and speeds up the return of normal gut function after surgery. It may also help stabilize blood sugar levels, which is important for recovery. However, limited evidence exists on its direct effect on newborns' blood sugar levels. Overall, it is considered helpful for mothers undergoing a cesarean, but its impact on newborns remains under study.14678
Are You a Good Fit for This Trial?
This trial is for non-laboring women over 18, planning a cesarean section at term with intact amniotic membranes, who speak English or Spanish. They must have fasted for at least 8 hours and completed glucose screening during pregnancy. Women in labor, with fetal anomalies, or a history of galactosemia cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Preparation
Participants receive a carbohydrate-rich drink two hours prior to cesarean section as part of the ERAS protocol
Surgery and Immediate Postoperative
Cesarean section is performed, and immediate postoperative care is provided
Follow-up
Participants are monitored for neonatal glucose levels and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Carbohydrate Preoperative Drink
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor
Nova Biomedical
Industry Sponsor